Literature DB >> 27896453

Management of phosphorus load in CKD patients.

Yutaka Taketani1, Fumihiko Koiwa2, Keitaro Yokoyama3.   

Abstract

Disturbances in mineral and bone metabolism play a critical role in the pathogenesis of cardiovascular complications in patients with chronic kidney disease (CKD). The term "renal osteodystrophy" has recently been replaced with "CKD-mineral and bone disorder (CKD-MBD)", which includes vascular calcification as well as bone abnormalities. In Japan, proportions of the aged and long-term dialysis patients are increasing which makes management of vascular calcification and parathyroid function increasingly more important. There are three main strategies to manage phosphate load: phosphorus dietary restriction, administration of phosphate binder and to ensure in the CKD 5D setting, an adequate dialysis.

Entities:  

Keywords:  CKD-MBD; Dietary management; Phosphate binder; Phosphorus

Mesh:

Substances:

Year:  2016        PMID: 27896453     DOI: 10.1007/s10157-016-1360-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  72 in total

1.  Association of disorders in mineral metabolism with progression of chronic kidney disease.

Authors:  Stephan Schwarz; Bhairvi K Trivedi; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Clin J Am Soc Nephrol       Date:  2006-05-17       Impact factor: 8.237

2.  Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.

Authors:  Masafumi Fukagawa; Keitaro Yokoyama; Fumihiko Koiwa; Masatomo Taniguchi; Tetsuo Shoji; Junichiro James Kazama; Hirotaka Komaba; Ryoichi Ando; Takatoshi Kakuta; Hideki Fujii; Msasaaki Nakayama; Yugo Shibagaki; Seiji Fukumoto; Naohiko Fujii; Motoshi Hattori; Akira Ashida; Kunitoshi Iseki; Takashi Shigematsu; Yusuke Tsukamoto; Yoshiharu Tsubakihara; Tadashi Tomo; Hideki Hirakata; Tadao Akizawa
Journal:  Ther Apher Dial       Date:  2013-06       Impact factor: 1.762

3.  Analysis of different thermal processing methods of foodstuffs to optimize protein, calcium, and phosphorus content for dialysis patients.

Authors:  Ivica Vrdoljak; Ines Panjkota Krbavčić; Martina Bituh; Tea Vrdoljak; Zoran Dujmić
Journal:  J Ren Nutr       Date:  2015-01-08       Impact factor: 3.655

4.  Impaired response of FGF-23 to oral phosphate in patients with type 2 diabetes: a possible mechanism of atherosclerosis.

Authors:  Koichiro Yoda; Yasuo Imanishi; Maki Yoda; Takashi Mishima; Mitsuru Ichii; Shinsuke Yamada; Katsuhito Mori; Masanori Emoto; Masaaki Inaba
Journal:  J Clin Endocrinol Metab       Date:  2012-08-14       Impact factor: 5.958

5.  Serum phosphorus levels associate with coronary atherosclerosis in young adults.

Authors:  Robert N Foley; Allan J Collins; Charles A Herzog; Areef Ishani; Philip A Kalra
Journal:  J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 10.121

6.  Phosphorus binders and survival on hemodialysis.

Authors:  Tamara Isakova; Orlando M Gutiérrez; Yuchiao Chang; Anand Shah; Hector Tamez; Kelsey Smith; Ravi Thadhani; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

7.  Diet shapes the ability of human intestinal microbiota to degrade phytate--in vitro studies.

Authors:  L H Markiewicz; J Honke; M Haros; D Świątecka; B Wróblewska
Journal:  J Appl Microbiol       Date:  2013-04-16       Impact factor: 3.772

8.  Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?

Authors:  Christian S Shinaberger; Sander Greenland; Joel D Kopple; David Van Wyck; Rajnish Mehrotra; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

Review 9.  Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis.

Authors:  Mark J Bolland; Alison Avenell; John A Baron; Andrew Grey; Graeme S MacLennan; Greg D Gamble; Ian R Reid
Journal:  BMJ       Date:  2010-07-29

10.  Patient education for phosphorus management in chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh
Journal:  Patient Prefer Adherence       Date:  2013-05-03       Impact factor: 2.711

View more
  5 in total

1.  An introduction to CKD-MBD research: restart for the future.

Authors:  Masafumi Fukagawa; Masaaki Inaba; Keitaro Yokoyama; Takashi Shigematsu; Ryoichi Ando; Ken-Ichi Miyamoto
Journal:  Clin Exp Nephrol       Date:  2017-03       Impact factor: 2.801

2.  Sucroferric Oxyhydroxide as Part of Combination Phosphate Binder Therapy among Hemodialysis Patients.

Authors:  Donald A Molony; Vidhya Parameswaran; Linda H Ficociello; Claudy Mullon; Robert J Kossmann
Journal:  Kidney360       Date:  2020-03-23

3.  The prevalence of fragmented QRS and its relationship with left ventricular systolic function in chronic kidney disease.

Authors:  Peng Liu; Jine Wu; Lu Wang; Dan Han; Chaofeng Sun; Jingjing Sun
Journal:  J Int Med Res       Date:  2019-12-24       Impact factor: 1.671

4.  25-hydroxyvitamin D-1α-hydroxylase (CYP27B1) induces ectopic calcification.

Authors:  Yilimulati Yimamu; Ayako Ohtani; Yuichiro Takei; Airi Furuichi; Yuki Kamei; Hisami Yamanaka-Okumura; Hirokazu Ohminami; Masashi Masuda; Makoto Miyazaki; Hironori Yamamoto; Yutaka Taketani
Journal:  J Clin Biochem Nutr       Date:  2022-06-04       Impact factor: 3.179

5.  The reliability and success of peritoneal dialysis during the COVID-19 pandemic.

Authors:  Hasan H Yeter; Ebru Gok Oguz; Omer F Akcay; Refika Karaer; Emre Yasar; Murat Duranay; Mehmet D Ayli; Galip Guz
Journal:  Semin Dial       Date:  2020-11-19       Impact factor: 2.886

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.